2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$3.99+$0.11 (+2.97%)
Price as of Oct 22, 2026 7:47 PM EDT- $107.8MMarket Cap
- -20.86%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$3.99+$0.11 (+2.97%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.87 | ||
Change | +$0.07 (+1.84%) | ||
Open | $4.08 | ||
High | $4.18 | ||
Low | $3.83 | ||
Previous Close | $3.80 | ||
Volume | 1,439,444 | ||
30-Day Average Volume | 992,776 | ||
1-Week Change | 4.59% | ||
1-Month Change | -18.87% | ||
1-Year Change | -20.86% | ||
3-Year Change | -55.51% | ||
5-Year Change | -85.23% | ||
Fundamentals | |||
Shares Outstanding | 27.9M | ||
Total Assets | $72.0M | ||
Market Cap | $107.8M | ||
Enterprise Value | $63.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$7.6M | ||
EBIT | -$1.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $52.6M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -65 | ||
PEG | -1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue